News

Dr. Antti Rahikkala was hired as Commercial Champion for Business Finland R2B project. Dr. Rahikkala has extensive expertise on drug delivery...

New research demonstrates how biohybrid and biodegradable nanovaccines can provide effective, personalised cancer treatment.

Very honored to be appointed Visiting Professor at the Shanghai Jiao Tong University School of Medicine, China (2021–2023). Very much looking...

The development of nanomedicines will change the paradigm on how we treat known diseases, says the professor of pharmaceutical nanotechnology.

GeneCellNano Flagship focuses on the innovation and commercial development of new biological drugs (so-called ATMP products), biomarkers and...

Oral delivery is, undoubtedly, the most preferred form of drug administration, but an unmet need for a vast number of therapeutic strategies...

We are very proud, pleased and delighted to announce that Dr. Wei Li received today the Young Researcher Award 2020 attributed by the Faculty of...

The USERN prize is an international award, established by the USERN, which would be annually bestowed to junior scientists or researchers less...